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Background: There remains controversy regarding which of the anthropometric indicators best defines obesity. In
this study, we compared the efficacy of using body mass index (BMI), waist circumference (WC) and waist-to-hip
ratio (WHR) in the diagnosis of obesity and assessed their associations with diabetes, hypertension, and dyslipidemia
in an urban working population in China.
Methods: Anthropometric measurements, blood pressure, plasma lipids, fasting and 2-hour plasma glucose (PG) levels
by a 75 gram oral glucose tolerance test (OGTT) were obtained from 2603 working Chinese who had no history of
cardiovascular diseases or diabetes. Cardio-metabolic risk factors including high blood pressure, dyslipidemia, and glucose
intolerance were evaluated. The diagnoses of overweight and obesity were based on the WHO definitions with BMI for
general obesity and WC and WHR for central obesity.
Results: Based on BMI, WC and WHR, there were 31.3%, 16.6%, 35.2% of the studied subjects, respectively, being
overweight and 2.0%, 5.6%, 9.2% being obese. Among women but not men, more overweight and obese subjects were
diagnosed using WHR and WC. The number of cardio-metabolic risks was higher by WC criterion than BMI and WHR in the
whole group (p <0.05) and female subjects (p <0.01). Comparing the three anthropometric indexes predicting hypertension,
hyperglycemia, dyslipidemia and multiple cardio-metabolic risks, for women, it was WC having the largest areas under ROC
curves (0.759, 0.746, 0.701 and 0.773 respectively); while in men, it was WC for hypertension, WHR for hyperglycemia, BMI
for dyslipidemia and WC for multiple cardio-metabolic risks (areas under ROC curves were 0.658, 0.686, 0.618 and 0.695
respectively).
Conclusions: Among Chinese working population, the need of lower cutoff values to define overweight and obesity were
observed. Central obesity indicator (WC) is the preferred measure to predict the presence of cardio-metabolic risk in Chinese
female subjects.
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The increasing prevalence of obesity is a major public
health problem worldwide. Wu et al. showed that there
were 14.7% of Chinese being overweight (body mass index,
BMI 25.0–29.9 kg/m2) and another 2.6% being obese (BMI
≥30.0 kg/m2) [1]. Obesity is a major independent risk factor
for metabolic disorders, such as diabetes, hypertension,* Correspondence: bianrw@126.com
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unless otherwise stated.insulin resistance and dyslipidemia. Their adverse effects on
physical and social functioning and quality of life were also
well documented [2,3].
Recently, many studies had been using different defini-
tions to classify obesity for Chinese, such as BMI ≥25 to
<27.5 kg/m2 as overweight and a BMI ≥27.5 kg/m2 as gen-
eral obesity [4], and a waist circumference (WC) ≥90 cm
in men or WC ≥80 cm in women as abdominal obesity
[5], while local experts in Mainland China adopted a BMI
≥24 to <28 kg/m2 as overweight and BMI ≥28 kg/m2 as
general obesity, and WC ≥85 cm for men and ≥80 cm for
women as abdominal obesity [6].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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have been proposed such as BMI, WC and waist-to-hip
ratio (WHR). However, controversy still exists regarding
which of these anthropometric indicators best defines
obesity. Their relationships with cardio-metabolic risk also
deserve further exploration. The aim of the present study
is to compare the efficacy of BMI, WC and WHR in the
diagnosis of obesity in a Chinese working population. We
also attempted to assess their respective associations with
diabetes, hypertension, and dyslipidemia by gender.
Research design and methods
We recruited 2603 subjects in Nanjing, an urban city of
China with a population of 5.5 million. The study was con-
ducted in the period between October 2003 and March
2005 (details of study procedure had been published previ-
ously) [7]. The survey was approved by Jiangsu Province
Health Administrative Department and Ethics Committee.
Every subject conxsented to participate in the study.
We measured body height, body weight, WC, Hip cir-
cumference with subjects in light clothing without shoes.
Fat mass (kg) and body fat percent (BF%) were assessed
with bioelectrical impedance equipment (TANITA, TBF-
300, France). The equation for BF% used by this model of
Tanita was developed by Brozek [8]:
BF% ¼ 4:57=body density−4:142ð Þ100
Venous blood was collected from the ante-cubital vein
after a 12-hour overnight fast. A 75 gram anhydrous glucose
load oral glucose tolerance test (OGTT) was performed
after fasting blood samples were collected. Blood for glucose
assay was containing sodium fluoride, and fasting plasma
glucose (FPG) and 2-hour plasma glucose (2hPG) levels
were determined by the glucose–oxidase method. Serum
total cholesterol (TC), high-density lipoprotein cholesterol
(HDL-C), and triglyceride (TG) concentrations were deter-
mined enzymatically. Low-density lipoprotein cholesterol
(LDL-C) was calculated using the Friedewald’s formula [9].
Serum fasting insulin (FINS) and 2-hour post-OGTT insulin
(2hINS) levels were measured by radioimmunoassay (RIA)
with BNIBT kits (North Institute of Biological Technology,
Beijing, China), of which the intra-assay coefficient of vari-
ation was below 10% and the inter-assay coefficient of vari-
ation was below 15%.
Homeostasis model assessment of insulin resistance
(HOMA-IR), an index which represents insulin resistance,
was calculated according to the following formula [10]:
HOMA‐IR ¼ FINS μU=mlð Þ  FPG mmol=Lð Þ½ =22:5
High HOMA-IR was defined as HOMA-IR ≥2.69 [11,12].
The homeostasis model assessment of β-cell function
(HOMA-β) was used to evaluate basal insulin secretion.
This was calculated as:HOMA‐β ¼ FINS μU=mlð Þ  20½ = FPG mmol=Lð Þ‐3:5½ 
Low HOMA-β was defined as HOMA-β ≤111.2 [13].
Definitions
Hypertension was defined as systolic and/or diastolic
blood pressure (BP) ≥140/90 mmHg and/or current use of
antihypertensive agents. Hyperglycemia was defined as
FPG ≥5.6 mmol/L and/or 2hPG ≥7.8 mmol/L or with
known diabetes history. Dyslipidmia was defined as having 1
or more of the following: TC ≥5.18 mmol/L, HDL-C
<1.04 mmol/L, LDL-C ≥3.37 mmol/L and TG ≥1.70 mmol/
L [14]. The presence of 2 or more of the above three cardio-
metabolic risk factors (i.e. hypertension, hyperglycemia, dys-
lipidemia) was defined as having “multiple metabolic risks”.
The diagnoses of overweight and obese were based on
World Health Organization (WHO) classification [15].
Those with a BMI of 25.0–29.9 kg/m2 were classified as
overweight, whilst those with a BMI ≥30.0 kg/m2 were clas-
sified as obese. Men with a WC of 94–101.9 cm and women
of 80–87.9 cm were classified as overweight, whilst men
with a WC ≥102.0 cm and women ≥88.0 cm were classified
as obese. Men with a WHR of 0.90–0.99 and women of
0.80–0.84 were classified as overweight, whilst men and
women with a WHR ≥1.00 and ≥0.85 were classified as
obese, respectively [15].
Statistical analysis
Statistical analysis was performed using the SPSS (version
15.0) software for Windows. Continuous variables were pre-
sented as mean ± SD and categorical data as number (%).
Difference in means between groups was tested using one-
way analysis of variance (ANOVA) and Chi-square (χ2) test
where appropriate. A p-value <0.05 (two-tailed) was consid-
ered to be statistically significant. The univariate analysis
and logistic regression analysis were conducted to compare
the differences among the 3 anthropometric indexes in their
relationships with hypertension, hyperglycemia and dyslipid-
emia. Receiver operating characteristic (ROC) curve analyses
and area-under-curve (AUC) were plotted and compared
with regard to their associations with various metabolic risk
factors, and were used to determine the optimal values for
BMI, WC and WHR in diagnosing obesity by gender. The
maximal Youden Index (YI), defined as the sum of specifi-
city and sensitivity minus one and its associated optimal cut-
off point on the ROC curves was also estimated.
Results
Of the 2603 subjects, 1590 (61.1%) were men and 1013
(38.9%) were women. Their mean age was 47.3 ± 11.6 years
(median 46 years, range 23 to 79 years). Compared to
women, men had higher BMI, WC, WHR, BP, PG, TG, in-
sulin levels, HOMA-IR, and more smokers, hypertension,
hyperglycemia and dyslipidemia, but lower HDL-C level,
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ing a high HOMA-IR level and one quarter of the whole
study group had a low HOMA-β level. Among the 1013
women, 365 (36.0%) were menopausal. As compared to
pre-menopausal women, those with menopause had worse
cardio-metabolic profiles (higher anthropometric parame-
ters, fat mass, BF%, BP, lipid profiles, glycemic indexes,Table 1 Clinical and biochemical characteristics of the 2603 C
Total (n = 2603)
Age (years) 47.3 ± 11.6
BMI (kg/m2) 23.7 ± 2.9
WC (cm) 82.5 ± 9.2
WHR 0.85 ± 0.06
Fat mass (kg) 26.1 ± 6.6
BF% 18.0 ± 5.7
SBP (mmHg) 119.9 ± 16.2
DBP (mmHg) 78.0 ± 10.1
TC (mmol/L) 4.99 ± 0.86
HDL-C (mmol/L) 1.41 ± 0.29
LDL-C (mmol/L) 2.96 ± 0.68
TG (mmol/L) 1.60 ± 1.11
Fasting PG (mmol/L) 5.0 ± 0.9
OGTT 2 hr PG (mmol/L) 6.4 ± 2.4
Fasting serum Insulin (uIU/ml) 12.7 ± 7.1
OGTT 2 hr serum Insulin (uIU/ml) 64.2 ± 49.1
HOMA-IR 2.85 ± 1.85
High HOMA-IR (%) 42.0
Homa-β 204.1 ± 177.0
Low HOMA-β (%) 25.3
Smoking (%) 31.5
Hypertension (%) 30.9
Newly diagnosed (%) 7.8







TC ≥5.18 mmol/L 40.2
HDL-C <1.04 mmol/L 9.0
LDL-C ≥3.37 mmol/L 25.5
TG ≥1.70 mmol/L 32.2
*p-value:comparing men and women.
BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; BF%, body
cholesterol; HDL-C and LDL-C, high- and low-density lipoprotein cholesterol; TG, trig
fasting glucose; IGT, impaired glucose tolerance; high HOMA-IR = HOMA-IR ≥2.69; lo
and 2 h PG <7.8 mmol/L; isolated IGT = fasting PG <6.1 mmol/L and 2 h PG ≥7.8 an
2 h PG ≥7.8 and <11.1 mmol/L; diabetes mellitus = fasting PG ≥7.0 mmol/L and/or 2higher Homa-IR and lower Homa-β) (detailed data not
shown).
According to BMI, WC and WHR criteria respectively,
31.3% (n = 816), 16.6% (431), 35.2% (917) subjects had
overweight and 2.0% (52), 5.6% (147), 9.2% (239) subjects
had obesity. Among women but not men, more over-
weight and obese subjects were diagnosed by WHR andhinese subjects
Men (n = 1590) Women (n = 1013) p-value*
47.6 ± 11.6 47.2 ± 11.6 0.373
24.4 ± 2.6 22.6 ± 3.0 0.000
86.3 ± 7.3 76.4 ± 8.6 0.000
0.89 ± 0.05 0.81 ± 0.05 0.000
24.5 ± 11.6 28.5 ± 7.3 0.000
17.7 ± 5.8 18.2 ± 5.6 0.044
122.8 ± 15.5 115.4 ± 16.3 0.000
80.3 ± 9.9 74.4 ± 9.3 0.000
4.98 ± 0.84 5.02 ± 0.89 0.213
1.35 ± 0.29 1.49 ± 0.28 0.000
2.95 ± 0.67 2.98 ± 0.70 0.239
1.82 ± 1.17 1.24 ± 0.89 0.000
5.1 ± 1.0 4.9 ± 0.8 0.000
6.6 ± 2.5 6.3 ± 2.2 0.003
13.0 ± 7.3 12.3 ± 6.9 0.010
65.9 ± 49.2 61.6 ± 48.6 0.030
2.98 ± 1.97 2.71 ± 1.76 0.000
45.3 36.9 0.004
















fat percent; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total
lyceride; OGTT, oral glucose tolerance test; PG, plasma glucose; IFG, impaired
w HOMA-β = HOMA-β ≤111.2; isolated IFG = fasting PG ≥6.1 and <7.0 mmol/L
d <11.1 mmol/L; combined IFG/IGT = fasting PG ≥6.1 and <7.0 mmol/L and/or
h PG ≥11.1 mmol/L.
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WC and WHR criteria, but only 38.5% when using BMI.
Using WC criteria, both obese men and women had
about 2 cardio-metabolic risk factors. The number of
cardio-metabolic risk factors was higher by WC criteria
than BMI and WHR in total (1.99 ± 0.93 vs. 1.85 ± 0.85
vs. 1.62 ± 0.98, respectively, p <0.05) and female subjects
(1.99 ± 0.93 vs. 1.95 ± 0.76 vs. 1.61 ± 0.97, respectively, p
<0.01), but no difference was found in male subjects or
between BMI and WHR criteria (2.0 ± 0.95 vs. 1.78 ±
0.91 vs. 1.86 ± 1.10, respectively, p-value: NS).
The percentage of subjects having cardio-metabolic
risk factors by the three anthropometric measures in-
creased as with obesity worsened. According to BMI,
WC and WHR criteria, 23.4%, 26.3% and 23.6% normal
subjects as well as 63.5%, 67.3% and 51.9% obese sub-
jects had multiple (2 or more) cardio-metabolic risk fac-
tors, respectively.
With logistic regression analysis, the odd-ratio (OR) of
hypertension, hyperglycemia, and dyslipidemia increased
as the anthropometric parameters increased (p-values all
<0.01). After adjustment for age and smoking in obese
women, WC had the highest OR in predicting hyperten-
sion and hyperglycemia, while WHR had the highest OR
to predict dyslipidemia.. Among obese men, WC for
hypertension and WHR for hyperglycemia had the high-
est OR (Table 2). All 3 anthropometric parameters lost
their statistical significance in predicting dyslipidemia in
obese male subjects. But among overweight men, WC
had the highest OR.
Table 3 shows the ROC curves to determine the ap-
propriate BMI, WC and WHR values for detecting the
presence of various metabolic risks in males and females
respectively. The cutoff value of BMI to predict multiple
metabolic risks were 24.6 kg/m2 and 22.6 kg/m2 in man
and women, respectively. Those of WC and WHR were
85.5 cm and 77.5 cm, 0.89 and 0.83 in men and women,
respectively. In women, the largest AUC were detected
by WC (respectively 0.759, 0.746, 0.701 and 0.773 for
hypertension, hyperglycemia, dyslipidemia and multiple
metabolic risks). While in men, the corresponding figures
were by WC for hypertension, WHR for hyperglycemia,
BMI for dyslipidemia and WC for multiple metabolic risks
(AUC= 0.658, 0.686, 0.618 and 0.695 respectively with
their 95% CIs overlapping with each other).
Discussion
To ensure comparability with other studies, our study
selected the criteria recommended by WHO classifica-
tions [4]. In this study, the prevalence of overweight/
obesity was 31.3%/ 2.0%, 16.6%/ 5.6%, 35.2%/ 9.2% by
BMI, WC and WHR respectively. These results exhibited
lower prevalence of overweight and obesity than those
seen in Western countries [16,17].In agreement with other South Asian and Chinese data
[18,19], our findings confirmed that quite a few subjects
with normal weight were already associated with many
cardio-metabolic risk factors and those with overweight or
obesity, their associated risks were even higher. In other
words, using a lower obesity cutoff value for Chinese popu-
lation appears to be reasonable in a general health preven-
tion point of view [20]. Nguyen et al. had suggested that
the optimal BMI cutoff value being 23–24 kg/m2 for
Chinese [21]. In the present study with Chinese working
population, the optimal BMI cutoff values to detect the
presence of multiple metabolic risk factors were
24.6 kg/m2 for men and 22.6 kg/m2 for women, while
the WC cutoff values were 85.5 cm for men and 77.5 cm
for women. All these values were closely approximate to
those being reported by many Japanese and Korean stud-
ies [22,23], while slightly higher than those by studies in
Hong Kong [24]. Actually, in the last international joint
statement of diagnosing metabolic syndrome published in
2009, a population- and country-specific definition for ele-
vated WC was highlighted [25]. Among Chinese and
Asian, a WC cutoff of 85–90 cm for men and 80 cm for
women were suggested to define abdominal obesity. These
figures were similar to what we have found in this study.
More women were diagnosed using central obesity in-
dexes (WC and WHR) than BMI, while men had similar
obese prevalence by all 3 measures. Interestingly, we also
found most centrally obese subjects were women. Simi-
lar findings were also obtained from a study in Iran that
the prevalence of abdominal obesity was much higher in
women (53.5%) than in men (12.5%) [26]. Hauner et al.
also reported that women more often had an increased
WC as compared to men [27]. All these findings sug-
gested the WC and WHR criteria for central obesity in
men may be too cautiously high. In accord to this, based
on HOMA-IR level correlating to metabolic parameters
among Japanese subjects, Kamezaki F et al. demon-
strated that WC cutoff level should be reduced and
more strictly managed [28].
It is well documented that WC more closely correlates
with the abdominal visceral fat than either WHR or BMI.
In agreement with our findings, most cross-sectional stud-
ies showed a stronger association of cardiovascular risk
factors with central obesity (based on WC or WHR) than
with general obesity (BMI) in Chinese as well as other eth-
nic populations [29-31]. The prospective AusDiab Study
confirmed that abdominal obesity was associated with
ORs between 2 and 5 for incident type 2 diabetes, dyslip-
idemia and hypertension at 5-year follow up [32].
Insulin resistance contributed largely to the under-
lying pathogenesis of hyperglycemia, hypertension and
dyslipidemia, while central obesity has been closely
linked to insulin resistance. Among Chinese teenagers, Yin
et al. have shown that those with 3 or more cardiovascular
Table 2 Multiple logistic regression analysis of the associations between BMI, WC, WHR and cardio-metabolic risks
OR (95% CI) Hypertension Hyperglycemia Dyslipidemia
Crude Adjusted for age Adjusted for
age and smoking
Crude Adjusted for age Adjusted for
age and smoking
Crude Adjusted for age Adjusted for
age and smoking
Men (n = 1590)
BMI overweight * 1.86 (1.46-2.35) * 2.15 (1.67-2.77) * 2.62 (2.08-3.30) * 1.42 (1.07-1.89) * 1.56 (1.16-2.09) * 2.15 (1.65-2.79) * 1.55 (1.21-1.98) * 1.54 (1.21-1.97) * 1.82 (1.45-2.28)
obese 0.78 (0.32-1.90) 0.93 (0.37-2.37) 1.72 (0.78-3.80) * 2.77 (1.16-6.63) * 3.41 (1.40-8.31) * 6.33 (2.92-13.72) 1.99 (0.73-5.47) 1.99 (0.72-5.47) 2.26 (0.96-5.30)
WC overweight 1.28 (0.91-1.79) 1.14 (0.80-1.62) * 2.01 (1.48-2.72) 1.18 (0.82-1.71) 1.08 (0.74-1.57) * 2.32 (1.69-3.20) 1.27 (0.87-1.87) 1.27 (0.87-1.87) * 1.94 (1.38-2.71)
obese * 3.04 (1.22-7.57) 2.88 (0.94-5.68) * 4.20 (1.86-9.47) * 2.44 (1.04-5.76) 1.84 (0.76-4.47) * 6.30 (2.89-13.70) 1.08 (0.41-2.84) 1.08 (0.41-2.84) 1.88 (0.83-4.25)
WHR overweight * 1.48 (1.16-1.88) * 1.46 (1.13-1.81) * 2.01 (1.60-2.53) * 2.31 (1.74-3.07) * 2.33 (1.75-3.11) * 2.97 (2.28-3.86) * 1.31 (1.03-1.68) * 1.31 (1.02-1.68) * 1.64 (1.31-2.05)
obese 2.38 (0.72-7.91) 2.19 (0.62-7.77) 2.81 (0.92-8.57) * 6.68 (2.03-22.00) * 6.48 (1.93-21.75) * 8.09 (2.68-24.37) 1.02 (0.30-3.50) 1.02 (0.30-3.50) 1.50 (0.47-4.85)
Women (n = 1013)
BMI overweight 1.32 (0.84-2.10) * 1.99 (1.20-3.29) * 3.12 (2.14-4.14) 0.73 (0.43-1.24) 0.97 (0.55-1.70) * 1.87 (1.25-2.81) 0.98 (0.57-1.67) 1.07 (0.60-1.92) 1.38 (0.88-2.16)
obese 1.33 (0.40-4.42) 2.26 (0.58-8.83) * 3.49 (1.16-10.50) 1.15 (0.34-3.96) 1.70 (0.45-6.40) * 3.15 (1.07-9.26) 1.88 (0.22-15.97) 3.47 (0.34-34.96) 1.86 (0.34-10.55)
WC overweight * 2.79 (1.74-4.47) 1.37 (0.82-2.28) * 1.92 (1.28-2.88) * 2.27 (1.33-3.88) 1.27 (0.73-2.23) * 1.71 (1.09-2.70) * 2.51 (1.48-4.23) 1.39 (0.77-2.52) 1.53 (0.98-2.40)
obese * 7.24 (3.67-14.31) * 2.17 (1.03-4.60) * 3.95 (2.35-6.63) * 6.86 (3.29-14.31) * 6.86 (1.17-5.62) * 3.34 (1.97-5.68) * 3.38 (1.42-8.03) 1.07 (0.39-2.93) 1.48 (0.74-2.97)
WHR overweight 1.19 (0.80-1.77) 0.96 (0.63-1.48) 1.16 (0.76-1.76) 1.10 (0.69-1.78) 0.95 (0.58-1.55) 0.88 (0.54-1.44) * 1.47 (1.06-2.04) 1.10 (0.77-1.59) 1.20 (0.84-1.72)
obese 1.18 (0.72-1.95) 1.10 (0.66-1.85) * 2.07 (1.36-3.17) * 1.94 (1.13-3.33) * 1.91 (1.12-3.27) * 2.44 (1.53-3.87) * 1.82 (1.09-3.06) 1.38 (0.76-2.52) * 1.64 (1.03-2.64)
Normal as reference (OR = 1), * p-value = statistically significant with p <0.05.
















Table 3 The cutoff values, sensitivity and specificity for cardio-metabolic risks by BMI, WC and WHR
BMI (kg/m2) WC (cm) WHR
Cutoff Se (%) Sp (%) YI Cutoff Se (%) Sp (%) YI Cutoff Se (%) Sp (%) YI
Men (n = 1590)
Hypertension 24.2 67.3 54.8 0.22 85.5 69.2 53.9 0.23 0.89 59.4 59.8 0.19
Hyperglycemia 24.9 57.5 61.2 0.19 88.5 55.3 68.4 0.24 0.91 55.9 73 0.29
Dyslipidemia 24.0 62.5 54.2 0.17 87.5 46.5 68.1 0.15 0.88 60.6 56.7 0.17
Multiple risk factors 24.6 63.8 63.0 0.27 85.5 72.8 55.6 0.28 0.89 63.4 62.8 0.26
Women (n = 1013)
Hypertension 22.9 69.9 66.8 0.37 77.5 67.7 70.2 0.38 0.82 65.0 66.8 0.32
Hyperglycemia 23.6 54.9 70.3 0.25 77.5 67.3 67.1 0.34 0.84 53.7 80.4 0.34
Dyslipidemia 22.2 58.7 68.6 0.27 75.5 58.7 74.2 0.33 0.81 55.5 67.8 0.23
Multiple risk factors 22.6 71.4 63.7 0.35 77.5 67.7 72.4 0.40 0.83 63.6 72.7 0.36
BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio, Se: Sensitivity, Sp: Specificity, YI: Youden Index.
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those without risk factors had a 4-fold increase in HOMA-
IR and a mean difference in WC of 23 cm [33]. Among Ca-
nadians of different ethnicities, Chateau-Degat et al. have
also demonstrated that those in the highest WC quartile
had the highest HOMA-IR highlighting the importance of
increased abdominal obesity on metabolic parameters [34].
Interestingly, they also showed that WC did not have a
similar deleterious impact according to ethnicity suggesting
the need for an ethnic-based definition.
Yet, some studies did not show consistently significant
differences between measures of general and central obes-
ity [35-37]. In the Decoda study, though diabetes had
stronger association with waist-to-stature ratio (WSR)
than BMI (p = 0.001) in men and a similar higher risk with
WC and WSR than BMI (both p <0.05) in women, they
also found that hypertension had stronger association with
BMI than WHR in men (p <0.001) and a highest risk with
BMI than other parameters in women [38]. It is now
widely accepted that, on the one hand, abdominal obesity
is a main predictive factor of cardio-metabolic risk, while
on the other hand, BMI, WC and WHR are all useful tools
for assessing adiposity in clinical practice [39,40].
The present study has its own limitations. This is a cross-
sectional epidemiological study with surrogate measures of
general and central obesity instead of direct measure of
body composition being used for analysis in the prediction
of metabolic risks. In addition, our subjects came from a
working population who might not be able to represent all
the socioeconomic status of the general population. The
biased nature of our sample was also expressed with more
than 40% of our subjects having a high HOMA-IR level
and up to a quarter of them having a low HOMA-β level,
suggesting a less favorable metabolic indices among our
study subjects. In accord to this, high risk for cardiovascular
disease and suboptimal health among working population
has been reported both in Chinese and Caucasians [41,42].Conclusion
In this study, the number of cardio-metabolic risk factors in-
creased with the degree of obesity in our Chinese working
population. The need for a lower cutoff values to define
overweight and obesity were observed. Men have a higher
prevalence of overweight or general obesity than women,
whereas women have a higher prevalence of abdominal
obesity than men. WC, being the most important central
obesity indicator, is the preferred measure to predict the
presence of cardio-metabolic risk in Chinese women. WC
also provides important information in Chinese men
on their cardio-metabolic risk while BMI supplements
significantly.
Abbreviations
BMI: Body mass index; WC: Waist circumference; WHR: Waist-to-hip ratio;
BP: Blood pressure; BF%: Body fat percent (BF%); OGTT: Oral glucose
tolerance test; FPG: Fasting plasma glucose; 2hPG: 2-hour plasma glucose;
TC: Total cholesterol; HDL-C: High-density lipoprotein cholesterol;
TG: Triglyceride; LDL-C: Low-density lipoprotein cholesterol; FINS: Fasting
insulin; 2hINS: 2-hour post-OGTT insulin; RIA: Radioimmunoassay;
HOMA-IR: Homeostasis model assessment of insulin resistance;
HOMA-β: Homeostasis model assessment of β-cell function; WHO: World
Health Organization; ANOVA: One-way analysis of variance; ROC: Receiver
operating characteristic; AUC: Area-under-curve; OR: Odd-ratio; WSR:
Waist-to-stature ratio.
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